Menopause + MHT Flashcards
What happens to the hormones in menopause?
Dec in oestrogen secretion by ovarian follicular unit –> inc gonadotrophins (LH and FSH from anterior pituitary
Remaining follicles are insensitive to FSH and LH
Perimenopause = beginning of missed cycles
What is perimenopause?
Transition before menopause (last 5 yrs)
physical and emotional changes, periods become irregular (heavy, long, or irregular)
What is menopause?
Permanent cessation of menstruation = all ovarian follicles depleted and ovarian oestrogen production ceases
Clinical = absence of menses for at least 12 consecutive months
Factors influencing symptoms = genetic predisposition, ovarian cystectomies
What does drug therapy for menopause aim to do? (general)
Treat:
- vasomotor symptoms
- vaginal dryness
- dyspareunia
Discuss menopausal vasomotor instability symptoms
Hot flush (75-85%) = directly proportional to drop in oestrogen - red face/neck, inc skin temp, inc heart rate
Nausea, dizziness, headache, palpitation
Formication
Common in last 12-24 of menstrual period
How is menopausal vasomotor instability treated?
W/ menopausal hormonal therapy (MHT)
Systemic estrogen –> best treatment for hot flushes
Intravaginal oestrogen –> less effective for hot flushes
Alternatively = clonidine –> menopausal flushing, use limited by ADRs
What is used to treat menopausal vasomotor instability if MHT is C/I?
Antidepressants, gabapentin = limited evidence that short term low dose treatment does anything to reduce hot flushes
Low dose SSRIs or SNRIs = short trials showed reduction in number/severity of hot flushes —> venlafaxine and paroxetine more effective
Discuss vaginal atrophy due to menopause
Oestrogen receptors in vagina, vulva, urethra –> des oestrogen –> atrophy of tissue
Physiological changes:
- dec subcutaneous fat and elasticity
- paleness and thinning of vaginal epithelium –> reduced secretion, distensibility
What are the symptoms of menopause vaginal atrophy?
Vaginal dryness
Pruritus, tears or bleeding, painful urination
painful sexual intercourse
Alkalinisation of vaginal pH –> more infections
Worsen with age
What are the treatments for vaginal atrophy due to menopause?
Systemic MHT = for those w/ systemic symptoms
Intravaginal oestrogen
Discuss menopausal urethral syndrome and its symptoms
Oestrogen receptors in trigone of bladder –> tissue atrophy and loss of pelvic tone
Symptoms = stress incontinence, urge incontinence
How is menopausal urethral syndrome treated?
Pelvic floor exercises
Systemic MHT
Intravaginal oestrogen
What are the risk factors to osteoporosis?
Slender, sedentary females
Caucasian or Asian descent
Smoking/alcohol use
Low intake of calcium and vitamin D
family history
Chronic steroid use
What is the treatment for CHD in menopausal women (pharm and lifestyle)?
Diet, exercise, +/- pharm drug therapy (lipid lowering agents)
Control of complications = diabetes, HTN, hypercholesterolaemia
Smoking cessation, moderation in alcohol consumption, stress reduction
Oestrogen replacement therapy (ERT) = inc HDL, dec LDL (transdermal oestrogen no effect here)
What effect would combined MHT have on menopausal CHD risk?
May attenuate or eliminate benefit on HDL cholesterol
Therapy limited to low doses, reserved for those w/ intact uterus
What tests should be conduction prior to menopausal treatment?
Full gynaecological hx and examination (breast, cervical, pelvis)
Mammography (>50 years of age)
blood pressure, blood lipids
complete blood examination
Thyroid stimulating hormone
bone density
What are some cancer risks with menopausal hormone therapy (MHT)?
Incidence of breast cancer inc w/ age
- Oral/transdermal inc breast cancer risk --> associated w/ duration of use, lower risk w/ cyclical treatment - Low dose vaginal oestrogen does not inc risk of breast cancer
Endometrial cancer (oestrogen only MHT)
- reduce risk w/ progestogen at least 10 days/month
What are additional risks associated w/ menopause hormone therapy?
Both oestrogen + combined therapy = Coronary heart disease (combined mostly), VTE (combined therapy), Stroke
What are C/I to systemic menopausal hormone therapy?
Aged >60 yrs
Previous or active thromboembolic disorder
Unexplained uterine bleeding
Severe liver disease
uncontrolled HTN
Breast cancer or other oestrogen dependent tumour
Cerebrovascular or coronary artery disease